Invention Grant
US09227962B2 Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative
有权
杂环取代的3-杂芳基-2-二氢吲哚酮衍生物
- Patent Title: Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative
- Patent Title (中): 杂环取代的3-杂芳基-2-二氢吲哚酮衍生物
-
Application No.: US14208289Application Date: 2014-03-13
-
Publication No.: US09227962B2Publication Date: 2016-01-05
- Inventor: Katsunori Tsuboi , Yosuke Takanashi , Shingo Tojo , Tomohiro Kodama , Katsumi Kubota , Toshio Kanai
- Applicant: Dainippon Sumitomo Pharma Co., Ltd.
- Applicant Address: US MA Cambridge
- Assignee: Boston Biomedical, Inc.
- Current Assignee: Boston Biomedical, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Arent Fox LLP
- Agent Yi Liu; Tony K. Uhm
- Main IPC: C07D403/14
- IPC: C07D403/14 ; C07D417/14 ; C07D409/14
Abstract:
Disclosed is a compound represented by formula (1) or a pharmacologically acceptable salt thereof. (In the formula, R1 is optionally substituted heteroaryl etc.; R2 is hydrogen etc.; R3 and R4 are each independently hydrogen etc., R5 is the following group: (wherein Y is optionally substituted five membered heteroaryl etc., R9a is optionally substituted aryl etc., R9b and R9c are each dependently hydrogen etc., and m is the integral 0 etc.) etc.; R6 is hydrogen etc.; and R7 is hydrogen etc.
Public/Granted literature
- US20140275076A1 HETEROCYCLIC SUBSTITUTED-3-HETEROARYLIDENYL-2-INDOLINONE DERIVATIVE Public/Granted day:2014-09-18
Information query
